Why Autoimmune Diseases Target Women Ninefold

Scientist analyzing DNA model on computer in laboratory
Photo: Gorodenkoff / Shutterstock

Scientists have found more than 1,000 genetic switches that work differently inside men’s and women’s immune cells, giving researchers a new clue to why women get autoimmune diseases like lupus so much more often than men.

Quick Take

  • Researchers identified over 1,000 sex-specific genetic switches, called eQTLs, in human immune cells
  • Most of these switches sit on regular chromosomes, not the X or Y sex chromosomes
  • The findings help explain why lupus strikes women about nine times more often than men
  • Female immune cells showed higher baseline activity in inflammation pathways linked to autoimmune disease

The Discovery: Over 1,000 Genetic Switches Found

A team of researchers used single-cell technology to study immune cells from men and women side by side. They found more than 1,000 genetic switches, known as expression trait quantitative loci, that behave differently depending on sex. These switches control how genes turn on and off inside immune cells. The scale of the finding surprised researchers, since sex differences in immune function were long assumed to trace mostly back to hormones or the sex chromosomes themselves.

The study, published in The American Journal of Human Genetics, also found 51 switches on autosomes, the chromosomes shared equally by men and women, that interact directly with sex to change gene activity. That detail matters. It shows the immune system’s sex differences run deeper than simple X and Y chromosome biology, reaching into the shared genetic code every person carries.

Why Most Switches Sit Outside the X and Y Chromosomes

Conventional thinking pointed to the X chromosome as the main driver of female-biased immune activity, partly because women carry two copies and men carry one. This new research flips that assumption. Researchers found the majority of sex-specific genetic switches actually sit on non-sex chromosomes, not X or Y, offering a fresh explanation for why lupus affects women roughly nine times more often than men.

That does not erase the X chromosome’s role. Decades of prior research show X-linked genes like FOXP3 and TLR7 influence immune regulation and autoimmune risk, and incomplete X-inactivation lets some genes escape silencing in female cells. The new autosomal findings add another layer to that picture rather than replacing it, painting a more complete map of how sex shapes immune gene activity throughout the entire genome.

Female Immune Cells Run Hotter on Inflammation

Beyond the genetic switches themselves, researchers found female immune cells showed higher baseline activity in inflammatory signaling pathways tied to autoimmune disease, particularly through tumor necrosis factor alpha signaling. Male immune cells, by contrast, showed stronger activity in genes related to ribosome function, a different biological process entirely. This split suggests female and male immune systems are not just tuned differently in strength but organized around different priorities at the cellular level.

Researchers describe this as a possible double-edged sword. A more reactive, inflammation-ready immune system may help women fight off infections faster, but that same heightened readiness appears to raise the risk that the immune system turns against the body’s own tissue, a hallmark of autoimmune conditions like lupus and multiple sclerosis.

How This Fits Decades of Research on Autoimmunity

Scientists have known for years that sex differences in autoimmune disease come from a mix of factors, not one single cause. Hormones, X chromosome inactivation, and genetic variation all play documented roles in shaping immune responses differently between men and women. This new study does not overturn that framework. It adds a substantial new piece, showing autosomal regulation deserves far more attention than it has historically received in explaining female-biased disease patterns.

Researchers now plan to explore whether these newly identified genetic switches can serve as targets for treatment, potentially allowing doctors to dial down harmful inflammation in autoimmune patients without weakening the immune system’s ability to fight real threats. That kind of precision would mark real progress for the millions of women living with conditions like lupus, rheumatoid arthritis, and multiple sclerosis, diseases that have long lacked cures and often demand lifelong management.

Sources:

sciencedaily.com, pubmed.ncbi.nlm.nih.gov, jci.org, x.com, earth.com